| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 14.11.2016 og
angivet som gældende fra 14.11.2016 (2833
dage). |
Ingen historik.
| Branche | | Engroshandel med medicinalvarer og sygeplejeartikler (464610). |
| Sidst opdateret den 20.04.2017 og
angivet som gældende fra 01.01.2017 (2785
dage). |
| Historik | Start | Stop |
|---|
| Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 01.01.2017 | |
| Bogføring og revision: skatterådgivning (692000) | 14.11.2016 | 31.12.2016 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 14.11.2016 og
angivet som gældende fra 14.11.2016 (2833
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | Novo Nordisk Denmark A/S. |
| Sidst opdateret den 08.10.2019 og
angivet som gældende fra 01.10.2019 (1782
dage). |
| Historik | Start | Stop |
|---|
| Novo Nordisk Denmark A/S | 01.10.2019 | |
| Novo Nordisk Region Europe Pharmaceuticals A/S | 14.11.2016 | 30.09.2019 |
| Binavne | | Novo Nordisk North West Europe Pharmaceuticals A/S. |
| Sidst opdateret den 01.05.2020 og
angivet som gældende fra 01.05.2020 (1569
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør. |
| Sidst opdateret den 14.11.2016 og
angivet som gældende fra 14.11.2016 (2833
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | 2 bestyrelsesmedlemmer + |
| 1 bestyrelsesmedlem + 1 direktør |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Deloitte, Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33963556
Virksomhedens regnskabsklasse:Regnskabsklasse C, stor virksomhed
Grundlag for konklusion (revision):Basis for conclusion
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of this auditor's report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Novo Nordisk Denmark A/S for the financial year 1 January - 31 December 2023, which comprise a summary of significant accounting policies, income statement, balance sheet, statement of changes in equity and notes, for the Company. The financial statements are prepared with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2023, and of the results of the it's operations for the financial year 1 January - 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review
Management is responsible for Management’s Review.
Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether Management’s Review provides the information required by relevant law and regulations.
Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements in the relevant law and regulations. We did not identify any material misstatement of Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration